The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives
Abstract
The effect of chronic (greater than 3 months) administration of low-dose oestrogen-containing (less than 50 micrograms oestrogen) oral contraceptives (OCS) on the pharmacokinetics of caffeine has been examined in a treated females matched with 9 non-smoking, drug-free, healthy control females of similar age, weight and ethnic origin. Each subject received 162 mg caffeine base orally after an overnight fast. OCS subjects had a prolonged elimination half-life of caffeine, (mean 7.88 h vs 5.37 h in the controls). This was the result of marked impairment of the plasma clearance of caffeine (1.05 vs 1.75 ml/min/kg, respectively) with no change in apparent volume of distribution (0.685 in OCS vs 0.7501/kg in the control group). The absorption parameters determined were peak plasma caffeine concentration (3.99 vs 4.09 micrograms/ml) and time to peak concentration after drug administration (1.52 vs 0.79), which was moderately prolonged in OCS users. Thus, caffeine clearance, previously reported to be a specific marker of cytochrome P-448 activity in man, is decreased by chronic OCS use. This suggests that OCS may cause significant impairment of this enzyme activity as assessed in vivo. With chronic caffeine consumption, OCS users are predicted to have an increased steady-state plasma caffeine concentration as compared to non-OCS users.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Factors such as the use of oral contraceptives, the specific phase of the menstrual cycle, and exogenous hormonal status can all influence *CYP1A2*-mediated caffeine metabolism, thereby altering the duration of systemic exposure to caffeine and its primary metabolites—such as paraxanthine and theophylline.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [100]
In the citing paper
“Given that the biological half-life of caffeine may be longer in women than in men, the trajectories of vascular responses, autonomic perturbations, changes in substrate utilization, and residual effects during the recovery phase may differ significantly in women compared to men, even when administered the same dosage [99,100].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [100]
In the citing paper
“Given that the biological half-life of caffeine may be longer in women than in men, the trajectories of vascular responses, autonomic perturbations, changes in substrate utilization, and residual effects during the recovery phase may differ significantly in women compared to men, even when administered the same dosage [99,100].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [100]
In the citing paper
“However, oral contraceptives can prolong caffeine half-life by inhibiting CYP1A2 activity [100], and the menstrual cycle phase may influence thermoregulation, vascular tone, and baseline cardiovascular status.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [100]
In the citing paper
“Oral contraceptives tend to double the half-life of caffeine (59).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [59]
Citations
Cites
Fundamentals of Clinical Pharmacokinetics
Wagner, J. G. (1975) · Medical Entomology and Zoology · Cited by 1,041
Fundamentals of clinical pharmacokinetics
Crouthamel, W. G. (1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600650639 · Cited by 668
Clinical Pharmacokinetics: (First of Two Parts)
Greenblatt, D. J., & Koch-Weser, J. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510022931406 · Cited by 433
The absolute bioavailability of caffeine in man
Blanchard, J., & Sawers, S. J. A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613933 · Cited by 378
Effect of smoking on caffeine clearance
Parsons, W. D., & Neims, A. H. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197824140 · Cited by 302
Clinical Pharmacokinetics: (Second of Two Parts)
Greenblatt, D. J., & Koch-Weser, J. (1975) · New England Journal of Medicine · doi:10.1056/nejm197511062931905 · Cited by 272
Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man
Kappas, A., Anderson, K. E., Conney, A. H., & Alvares, A. P. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976206643 · Cited by 264
Polychlorinated Biphenyls: A New Type of Inducer of Cytochrome P-448 in the Liver
Alvares, A. P., Bickers, D. R., & Kappas, A. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.5.1321 · Cited by 263
Variability in caffeine metabolism
Grant, D. M., Tang, B. K., & Kalow, W. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.80 · Cited by 254
Plasma and salivary pharmacokinetics of caffeine in man
Newton, R., Broughton, L. J., Lind, M. J., Morrison, P. J., Rogers, H. J., & Bradbrook, I. D. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609587 · Cited by 193
Research works printed but not linked: 1
- Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker New York
Cited by
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
“The apparent volume of distribution of caffeine is increased by 60% in obese subjects, but obesity has no effect on caffeine clearance and seems to prolong caffeine half-life by 31%–69% (Abernethy and Todd, 1985; Kamimori et al., 1987).”
BackgroundScientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613
“Caffeine has a plasma half-life of about four hours with range of about two to eight hours (Knutti et al., 1981; Abernethy and Todd, 1985; Abernethy et al., 1985; Balogh et al., 1995).”
BackgroundResultThe Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557
“Oral contraceptives tend to double the half-life of caffeine (59).”
BackgroundClinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
Carrillo, J. A., & Benitez, J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00004 · Cited by 364
Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action
Magkos, F., & Kavouras, S. A. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040-830491379245 · Cited by 344
Ghotbi, R., Christensen, M., Roh, H.-K., Ingelman-Sundberg, M., Aklillu, E., & Bertilsson, L. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0288-2 · Cited by 264
“Previous studies have shown that smoking induces CYP1A2 [7] via the aryl hydrocarbon receptor and that OCs inhibit CYP1A2 [9].”
BackgroundPharmacokinetics and metabolism of natural methylxanthines in animal and man
Arnaud, M. J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_3 · Cited by 259
Gunes, A., & Dahl, M.-L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.625 · Cited by 256
Southward, K., Rutherfurd-Markwick, K. J., & Ali, A. (2018) · Sports Medicine · doi:10.1007/s40279-018-0939-8 · Cited by 254
“A number of factors can influence individual responses and metabolism of caffeine including smoking [83], age [84] and gender [85].”
BackgroundEffects of caffeine on neuromuscular function
Kalmar, J. M., & Cafarelli, E. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.2.801 · Cited by 249
Rasmussen (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00008 · Cited by 241
Immunomodulatory effects of caffeine: Friend or foe?
HORRIGAN, L., KELLY, J., & CONNOR, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.002 · Cited by 240
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234
Pharmacokinetic drug interactions with oral contraceptives
Back, D. J., & Orme, M. L. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018060-00004 · Cited by 209
Pickering, C., & Kiely, J. (2018) · Sports Medicine · doi:10.1007/s40279-017-0776-1 · Cited by 209
“This information could potentially be paired with knowledge of individual variation in other factors, such as circadian rhythm [76, 77], habitual caffeine use [58–60], medication intake [66, 67], and expectancy [80, 81, 83], all of which also impact the magnitude of performance enhancement seen after caffeine ingestio…”
BackgroundGreer, F., Hudson, R., Ross, R., & Graham, T. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2349 · Cited by 206
Body weight, lifestyle, dietary habits and gastroesophageal reflux disease
Festi, D., Scaioli, E., Baldi, F., Vestito, A., Pasqui, F., Biase, A. R. D., & Colecchia, A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1690 · Cited by 135
Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins
Zheng, Z., Nordenstedt, H., Pedersen, N. L., Lagergren, J., & Ye, W. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.019 · Cited by 137
Grosso, L. M., & Bracken, M. B. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.12.011 · Cited by 173
Menstrual cycle effects on caffeine elimination in the human female
Lane, J. D., Steege, J. F., Rupp, S. L., & Kuhn, C. M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02285099 · Cited by 170
“In three studies of OCS effects [4, 5, 7], OCS use was associated with increases in tl~ of 47 % to 235 % and with reductions in caffeine clearance ranging from 39 % to 66%.”
BackgroundEffect of caffeine on perceptions of leg muscle pain during moderate intensity cycling exercise
Motl, R. W., O’Connor, P. J., & Dishman, R. K. (2003) · The Journal of Pain · doi:10.1016/s1526-5900(03)00635-7 · Cited by 166
Acute and chronic effects of caffeine on performance, mood, headache, and sleep
James, J. E. (1998) · Neuropsychobiology · doi:10.1159/000026514 · Cited by 157
Xu, K., Xu, Y., Brown-Jermyn, D., Chen, J., Ascherio, A., Dluzen, D. E., & Schwarzschild, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3008-05.2006 · Cited by 146
“Human data (Patwardhan et al., 1980; Abernethy and Todd, 1985; Pollock et al., 1999) have demonstrated that caffeine metabolism is inhibited in women taking estrogen-containing oral contraceptives or estrogen replacement therapy after menopause, suggesting that the actions of caffeine would be enhanced rather than att…”
BackgroundNakajima, M., Yokoi, T., Mizutani, M., Shin, S., Kadlubar, F. F., & Kamataki, T. (1994) · PubMed · Cited by 141
Carrillo, J. A., Christensen, M., Ramos, S., Alm, C., Dahl, M., Benítez, J., & Bertilsson, L. (2000) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200008000-00008 · Cited by 136
The Influence of Caffeine on Voluntary Muscle Activation
Kalmar, J. M. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000178219.18086.9e · Cited by 135
Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions
Plaskett, C., & CAFARELLI, E. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1535 · Cited by 134
Tsutsumi, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116495 · Cited by 124
Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women
Pollock, B. G., Wylie, M. E., STACK, J. A., Sorisio, D. A., Thompson, D. S., Kirshner, M. A., Folan, M., & Condifer, K. A. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008560 · Cited by 121
Caffeine Affects Cardiovascular and Neuroendocrine Activation at Work and Home
Lane, J. D., Pieper, C. F., Phillips-Bute, B. G., Bryant, J. E., & Kuhn, C. M. (2002) · Psychosomatic Medicine · doi:10.1097/01.psy.0000021946.90613.db · Cited by 122
“Women who used oral contraceptive steroids were excluded because these drugs are known to slow the metabolism and elimination of caffeine, increasing the half-life three-fold (24, 25).”
BackgroundAlterations in drug disposition during pregnancy: implications for drug therapy
Hodge, L. S., & Tracy, T. S. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.4.557 · Cited by 128
“However, studies examining this relationship have found no correlation between either estrogen or progesterone levels and CYP1A2 activity [7,34] .”
BackgroundCaffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer
Tworoger, S. S., Gertig, D. M., Gates, M. A., Hecht, J. L., & Hankinson, S. E. (2008) · Cancer · doi:10.1002/cncr.23275 · Cited by 112
“This may be because hormones, particularly estradiol, can interfere with caffeine metabolism.(55,56) However, these results need to be replicated in other prospective studies.”
ResultGranfors, M. T., Backman, J. T., Laitila, J., & Neuvonen, P. J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.009 · Cited by 113
White, J. R., Padowski, J. M., Zhong, Y., Chen, G., Luo, S., Lazarus, P. J., Layton, M. E., & McPherson, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2016.1146740 · Cited by 122
Grzegorzewski, J., Bartsch, F., Köller, A., & König, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.752826 · Cited by 108
“Only a small subset of studies was specifically designed to study these questions (e.g. smoking by (Benowitz et al., 2003; Gunes et al., 2009; Parsons and Neims, 1978; Backman et al., 2008) and oral contraceptives by (Patwardhan et al., 1980; Abernethy and Todd, 1985; Rietveld et al., 1984)).”
BackgroundImpact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease
Camandola, S., Plick, N., & Mattson, M. P. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2492-0 · Cited by 119
“The gender disparities suggested by epidemiological studies are substantiated by human studies showing that caffeine metabolism is inhibited in women taking estrogen either in oral contraceptives or as replacement supplements after menopause [160, 161].”
BackgroundInduction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
Djordjević, N., Ghotbi, R., Јаnkovic, S., & Aklillu, E. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0823-4 · Cited by 111
“On the other hand, it is known that cigarette smoking induces and oral contraceptive use inhibits CYP1A2 [28, 29].”
BackgroundLucas, M., O’Reilly, E. J., Pan, A., Mirzaei, F., Willett, W. C., Okereke, O. I., & Ascherio, A. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.795243 · Cited by 103
O’Connor, P. J., Motl, R. W., Broglio, S. P., & Ely, M. R. (2004) · Pain · doi:10.1016/j.pain.2004.01.017 · Cited by 104
“Women were not tested in this study to avoid confounding the experimental manipulation by a reduced rate of caffeine clearance both during the late luteal phase of the menstrual cycle (Lane et al., 1992) and among oral contraceptive users (Abernethy and Todd, 1985).”
BackgroundBehrens, M., Mau‐Moeller, A., Weippert, M., Fuhrmann, J., Wegner, K., Skripitz, R., Bader, R., & Bruhn, S. (2015) · Scientific Reports · doi:10.1038/srep10209 · Cited by 106
Meyers, B. M., & CAFARELLI, E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00937.2004 · Cited by 98
“Only men were recruited, because oral contraceptive use increases the half-life of caffeine and its clearance is diminished during the luteal phase of the menstrual cycle (1, 32).”
BackgroundCaffeine increases spinal excitability in humans
Walton, C., Kalmar, J. M., & CAFARELLI, E. (2003) · Muscle & Nerve · doi:10.1002/mus.10457 · Cited by 98
“The results of the two-way repeated measures ANOVA (caffeine/placebo pretest/ posttest) revealed a significant interaction [F(6,1) 6.”
Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women
McLean, C., & Graham, T. E. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00762.2000 · Cited by 100
“Although in a review (4) it was stated that there are no gender differences in caffeine metabolism, oral contraceptive use (1, 26, 27) and pregnancy (2) result in a decrease in caffeine elimination.”
BackgroundCaffeine in tea Camellia sinensis — Content, absorption, benefits and risks of consumption
Gramza‐Michałowska, A. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0404-1 · Cited by 103
“…postmenopausal women on estrogen replacement therapy (95). it is also proved that oral contraceptive use could double the caffeine half-life (1). it was proven that caffeine reduced reaction time and enhanced the accuracy on vigilance tasks in dose dependent manner. research results showed…”
Palovaara, S. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00202-9 · Cited by 87
Damoiseaux, V. A., Proost, J. H., Jiawan, V. C. R., & Melgert, B. N. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0145-2 · Cited by 99
“The finding that low-dose estrogen-containing contraceptives impair caffeine clearance, a well-known CYP1A2 substrate, also implies that estrogen is involved in decreasing CYP1A2 activity [73].”
BackgroundEffect of caffeine on self‐sustained firing in human motor units
Walton, C., Kalmar, J. M., & CAFARELLI, E. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.025064 · Cited by 90
“Males were selected since the use of oral contraceptives increases the plasma half-life of caffeine by decreasing the activity of hepatic oxygenase, the enzyme which catalyses the breakdown of caffeine into paraxanthine (Abernethy & Todd, 1985).”
MethodEffect of Caffeine on Leg Muscle Pain during Cycling Exercise among Females
Motl, R. W., O’Connor, P. J., Tubandt, L., Puetz, T., & Ely, M. R. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000193558.70995.03 · Cited by 85
Caffeine and Exercise Performance: Possible Directions for Definitive Findings
Martins, G. L., Guilherme, J. P. L. F., Ferreira, L. H. B., de Souza, T. P., & Lancha, A. H. (2020) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2020.574854 · Cited by 106
“One possible explanation is related to the complexity of assessing the effects of caffeine on women since both oral contraceptives (Rietveld et al., 1984; Abernethy and Todd, 1985) and the different phases of the menstrual cycle (Lane et al.”
BackgroundRasmussen, B. B., & Brøsen, K. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199606000-00006 · Cited by 80
Kalmar, J. M., & CAFARELLI, E. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.03.006 · Cited by 79
Central excitability does not limit postfatigue voluntary activation of quadriceps femoris
Kalmar, J. M., & CAFARELLI, E. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01347.2005 · Cited by 79
“We did not use women in this study because cortical excitability fluctuates during the menstrual cycle (53) and because caffeine clearance is diminished during the luteal phase of the menstrual cycle (31) and by oral contraceptive use (1).”
MethodGrosso, L. M., Triche, E. W., Belanger, K. D., Benowitz, N. L., Holford, T. R., & Bracken, M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj125 · Cited by 74
“Pregnancy, as well as oral contraceptive use, is associated with a marked reduction in CYP1A2 activity because of the inhibitory effects of sex hormones ( 29 ).”
BackgroundLechien, J. R., Bobin, F., Muls, V., Horoi, M., Thill, M., Dequanter, D., Rodriguez, A., & Saussez, S. (2019) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-019-05711-2 · Cited by 71
Nehlig, A., & Debry, G. (1994) · Journal of the American College of Nutrition · doi:10.1080/07315724.1994.10718366 · Cited by 69
Clinical Pharmacokinetics of Contraceptive Steroids
Shenfield, G. M., & Griffin, J. M. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120010-00002 · Cited by 71
Predicted metabolic drug clearance with increasing adult age
Polasek, T. M., Patel, F., Jensen, B. P., Sorich, M. J., Wiese, M. D., & Doogue, M. P. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04446.x · Cited by 77
Effects of dietary caffeine on mood when rested and sleep restricted
James, J. E., & Gregg, M. E. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.589 · Cited by 71
“Cigarette smokers and users of oral contraceptive steroids were excluded, because the elimination half-life of caffeine is significantly decreased by smoking (Parsons and Neims, 1978) and significantly increased by oral contraceptives (Abernethy and Todd, 1985).”
BackgroundPerera, V., Gross, A. S., & McLachlan, A. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.139 · Cited by 75
The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women
Nordmark, A., Lundgren, S., Ask, B., Granath, F. N., & Rane, A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01673.x · Cited by 60
Palovaara, S., Tybring, G., & Laine, K. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01868.x · Cited by 61
Lechien, J. R., Bobin, F., Mouawad, F., Zeleník, K., Calvo‐Henríquez, C., Chiesa-Estomba, C. M., Enver, N., Nacci, A., Barillari, M. R., Schindler, A., et al. (2019) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-019-05631-1 · Cited by 58
Prenatal Caffeine Assessment: Fetal and Maternal Biomarkers or Self-Reported Intake?
Grosso, L. M., Triche, E. W., Benowitz, N. L., & Bracken, M. B. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.11.005 · Cited by 57
Шелепова, Т. Н., Nafziger, A. N., Victory, J. M., Kashuba, A. D. M., Rowland, E., Zhang, Y., Sellers, E. M., Kearns, G. L., Leeder, J. S., Gaedigk, A., et al. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005280851 · Cited by 57
Hemodynamic effects of dietary caffeine, sleep restriction, and laboratory stress
James, J. E., & Gregg, M. E. (2004) · Psychophysiology · doi:10.1111/j.1469-8986.2004.00248.x · Cited by 58
Caffeine and stress alter salivary α‐amylase activity in young men
Klein, L. C., Bennett, J. M., Whetzel, C. A., Granger, D. A., & Ritter, F. E. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1126 · Cited by 46
Chronic Effects of Habitual Caffeine Consumption on Laboratory and Ambulatory Blood Pressure Levels
James, J. E. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100210 · Cited by 53
Timmins, T. D., & Saunders, D. H. (2014) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000000447 · Cited by 56
“Women were deliberately excluded from the study, as caffeine clearance is attenuated during the luteal phase of the menstrual cycle (30) and oral contraceptive increases the half-life of caffeine (1).”
BackgroundThe impact of daily caffeine intake on nighttime sleep in young adult men
Weibel, J., Lin, Y.-S., Landolt, H.-P., Kistler, J., Rehm, S., Rentsch, K. M., Slawik, H., Borgwardt, S., Cajochen, C., & Reichert, C. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-84088-x · Cited by 52
Shah, D., Patil, M., & On behalf of the National PCOS Working Group (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_72_18 · Cited by 51
“[21] The concentration of theophylline, prednisolone, caffeine, and cyclosporine is also reduced in OCP users.[22] Thus, lower doses of these drugs may be effective in OCPs users The clearance of temazepam, salicylic acid, paracetamol, morphine, and clofibric acid apparently is increased.”
BackgroundEffects of moderate exercise on the pharmacokinetics of caffeine
Collomp, K., Anselme, F., Audran, M., Gay, J. P., Chanal, J. L., & Prefaut, C. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315209 · Cited by 51
“Previous studies [3, 16] have not demonstrated a difference in caffeine metabol ism between men and women, except in the case of pregnancy or use of oral contraception [17].”
BackgroundOral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics*
Slayter, K., Ludwig, E. A., Lew, K. H., Middleton, E., Ferry, J. J., & Jusko, W. J. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80009-9 · Cited by 50
Ali, A., O’Donnell, J., von Hurst, P. R., Foskett, A., Holland, S., Starck, C. S., & Rutherfurd-Markwick, K. J. (2015) · Journal of Sports Sciences · doi:10.1080/02640414.2015.1052746 · Cited by 50
“…females in sport (Del Coso et al., 2011), as well as the sex-related differences (e.g. differing concentrations of sex hormones, lean body mass, effect of contraceptives) reported for caffeine metabolism (Abernethy & Todd, 1985; Lane, Steege, Rupp, & Kuhn, 1992), research in this area is necessary.”
BackgroundInfluentialKarjalainen, M. J., Neuvonen, P. J., & Backman, J. T. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00252.x · Cited by 47
Frovatriptan: A Review of Drug‐Drug Interactions
Buchan, P., Wade, A., Ward, C., Oliver, S. D., Mfpm, Stewart, A. J., & Freestone, S. H. (2002) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.42.s2.4.x · Cited by 47
Mendoza, N., Ramírez, I. C., de la Viuda, E., Coronado, P., Baquedano, L., Llaneza, P., Nieto, V., Otero, B., Sánchez, S., de Frutos, V. Á., et al. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.08.008 · Cited by 64
Caffeinated clues from epidemiology of Parkinson’s disease
Ascherio, A., & Chen, H. (2003) · Neurology · doi:10.1212/01.wnl.0000095213.86899.21 · Cited by 47
Romero-Moraleda, B., Del Coso, J., Gutiérrez-Hellín, J., & Lara, B. (2019) · Nutrients · doi:10.3390/nu11112662 · Cited by 44
“In this sense, the administration of low-doses of estrogen-containing oral contraceptives reduces the rate of plasma clearance of caffeine and increases the time necessary to reach peak plasma caffeine concentration [18].”
BackgroundReichert, C., Veitz, S., Bühler, M., Gruber, G., Deuring, G., Rehm, S., Rentsch, K., Garbazza, C., Meyer, M., Slawik, H. C., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114283 · Cited by 57
Griseofulvin and Fluvoxamine Interactions with the Metabolism of Theophylline
Rasmussen, B. B., Jeppesen, U., Gaist, D., & Brøsen, K. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199702000-00010 · Cited by 44
Sun, H., Sivasubramanian, R., Vaidya, S. S., Barve, A., & Jarugula, V. R. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1765 · Cited by 58
Caffeine Supplementation and Reactive Agility in Elite Youth Soccer Players
Jordan, J. B., Korgaokar, A., Farley, R. S., Coons, J. M., & Caputo, J. L. (2014) · Pediatric Exercise Science · doi:10.1123/pes.2013-0134 · Cited by 45
Caffeine ingestion impairs insulin sensitivity in a dose-dependent manner in both men and women
Beaudoin, M., Allen, B., Mazzetti, G., Sullivan, P. J., & Graham, T. E. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0201 · Cited by 44
“While McLean and Graham (2002) reported that there were no sex differences in the pharmacokinetics of caffeine, there are reports that caffeine metabolism is influenced by oral contraceptives (Patwardhan et al. 1980; Rietveld et al. 1984; Abernethy and Todd 1985) and pregnancy (Aldridge et al.”
BackgroundDrug-drug interactions between psychotropic medications and oral contraceptives
Schoretsanitis, G., Deligiannidis, K. M., Paulzen, M., Spina, E., & de León, J. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2106214 · Cited by 45
“We only provided dose-correction factors for the inhibitory effects of estrogens on CYP1A2 substrates and they should be periodically updated as new data becomes available.”
BackgroundInfluentialRegular Caffeine Intake Delays REM Sleep Promotion and Attenuates Sleep Quality in Healthy Men
Weibel, J., Lin, Y.-S., Landolt, H., Berthomier, C., Brandewinder, M., Kistler, J., Rehm, S., Rentsch, K., Meyer, M., Borgwardt, S., et al. (2021) · Journal of Biological Rhythms · doi:10.1177/07487304211013995 · Cited by 55
“To minimize the potential confounding influence by the menstrual cycle and the use of oral contraceptives on sleep (Shechter and Boivin, 2010) as well as caffeine elimination (Abernethy and Todd, 1985; Balogh et al., 1995), female individuals were not included in this study.”
BackgroundInfluentialJames, J. E., Gregg, M. E., Kane, M., & Harte, F. (2005) · Neuropsychobiology · doi:10.1159/000086172 · Cited by 40
“and significantly increased by oral contraceptives [”
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Henriques, B. C., Yang, E. H., Lapetina, D. L., Carr, M. S., Yavorskyy, V., Hague, J., & Aitchison, K. J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.491895 · Cited by 42
Factors influencing serum caffeine concentrations following caffeine ingestion
Skinner, T. L., Jenkins, D. G., Leveritt, M. D., McGorm, A., Bolam, K. A., Coombes, J. S., & Taaffe, D. R. (2014) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2013.07.006 · Cited by 39
Pickering, C., & Kiely, J. (2019) · Nutrition · doi:10.1016/j.nut.2019.06.016 · Cited by 47
Mostofsky, E., Mittleman, M. A., Buettner, C., Li, W., & Bertisch, S. M. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.02.015 · Cited by 42
Perera, V., Gross, A. S., Polasek, T. M., Yan, Q., Rao, G. G., Forrest, A., Xu, J., & McLachlan, A. J. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.795540 · Cited by 41
“Oral contraceptives (OCs) are well-known inhibitors of CYP1A2 activity [70-73].”
BackgroundChen, B., Ding, L., Qin, Q., Lei, T., Girard, O., & Cao, Y. (2024) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2024.2363789 · Cited by 46
“First, our analysis did not include factors such as dietary habit (alcohol and cigarettes), gender, and genetic type, which have been proven to influence the metabolic effects of caffeine [18,60,61].”
MethodHilli, J., Korhonen, T., Turpeinen, M., Hokkanen, J., Mattila, S., & Laine, K. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008318669 · Cited by 38
Grgić, J., Pickering, C., Coso, J. D., Schoenfeld, B. J., & Mikulić, P. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02427-6 · Cited by 50
In vitroprooxidant effect of caffeine
Gülçın, İ. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701306404 · Cited by 35
“On the other hand, the caffeine half-life is approximately doubled in women taking oral contraceptives [26,27].”
BackgroundEffects of caffeine on alertness as measured by infrared reflectance oculography
Michael, N. J., Johns, M. W., Owen, C., & Patterson, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1202-z · Cited by 36
“Two female participants did report use of oral contraceptives, and one smoked on a regular basis, which could have interacted with the caffeine administered during the study (Abernethy and Todd 1985; Parsons and Neims 1978).”
BackgroundBiological sex differences in pharmacokinetics and adverse drug reactions
Aljohmani, A., & Yildiz, D. (2026) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-025-04721-8 · Cited by 35
“…and Orme 1990; Meffin et al. 1984; Abernethy et al. 1982b; Abernethy et al. 1984; Edelbroek et al. 1987; Sandberg et al. 2004; Granfors et al. 2005; Matthaei et al. 2016; Abernethy and Todd 1985; Gu et al. 1992; Tornatore et al. 1982; Tamminga et al. 1999; Laine et al. 1999; Bram-ness et al. 2005).”
The Effect of Caffeine Ingestion during Evening Exercise on Subsequent Sleep Quality in Females
Ali, A., O’Donnell, J., Starck, C. S., & Rutherfurd-Markwick, K. J. (2015) · International Journal of Sports Medicine · doi:10.1055/s-0034-1398580 · Cited by 45
Begdache, L., Sadeghzadeh, S., Derose, G., & Abrams, C. (2020) · Nutrients · doi:10.3390/nu13010024 · Cited by 42
“Therefore, the breakdown of caffeine is reduced in the presence of circulating estrogen, use of oral contraceptive, or hormone replacement therapy [64,65].”
BackgroundPCB Exposure and in Vivo CYP1A2 Activity among Native Americans
Fitzgerald, E. F., Hwang, S., Lambert, G. H., Gómez, M. I., & Tarbell, A. M. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.7370 · Cited by 34
“Oral contraceptive use appears to inhibit CYP1A2 activity in vivo (Abernethy and Todd 1985; Campbell et al. 1987b; Rietveld et al. 1984), thereby delaying caffeine metabolism.”
Background
Metadata
- Authors
- Abernethy, D. R., & Todd, E. L.
- Affiliations
- Baylor College of Medicine (US)
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1985
- Volume
- 28
- Issue
- 4
- Pages
- 425-428
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2021943540
- Cited by
- 195
- References
- 38
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 19 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 7 · 2013: 7 · 2012: 5
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health (AM 32050)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- caffeine, oral contraceptives, estrogen, drug interactions, caffeine clearance, elimination half-life, pharmacokinetics, cytochrome P-448, enzyme inhibition, volume of distribution, absorption
- MeSH terms
- Adult, Caffeine, Contraceptives, Oral, Contraceptives, Oral, Hormonal, Cytochrome P-450 Enzyme System, Drug Interactions, Estrogens, Female, Humans, Liver, Metabolic Clearance Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.